Explore more about: Lung Disease

March 31, 2021
News
Researchers have generated synthetic mucins with a polymer backbone that more accurately mimics the structure and function of naturally occurring mucins. They also showed that these synthetic mucins could effectively neutralize the bacterial toxin that causes cholera.
September 17, 2020
News
Researchers have created a new PET imaging agent that detects signs of inflammation. Such a tracer could aid diagnosis and study of diseases ranging from cardiovascular disease to cancer to COVID-19.
August 26, 2020
News
A new article looks at the use of virtual imaging trials in effective assessment and optimization of CT and radiography acquisitions and analysis tools to help manage the coronavirus disease (COVID-19) pandemic.
August 10, 2020
News
The National Institutes of Health has launched an ambitious effort to use artificial intelligence, computation, and medical imaging to enable early disease detection, inform successful treatment strategies, and predict individual disease outcomes of COVID-19.
August 3, 2020
News
A new technique funded by NIBIB and developed by University of Minnesota researchers allows 3D printing of hydrogel-based sensors directly on the surface of organs, such as lungs—even as they expand and contract. The technology was developed to support robot-assisted medical treatments.
August 3, 2020
News
NIBIB-funded researchers at Stanford University have created an artificial neural network that analyzes lung CT scans to provide information about lung cancer severity that can guide treatment options.
June 18, 2020
News
Mechanical engineers and computer scientists have developed a 3D printing technique that uses motion capture technology, similar to that used in Hollywood movies, to print electronic sensors directly on organs that are expanding and contracting.
December 3, 2020
News
Tuberculosis meningitis causes life-threatening inflammation of the membranes in the brain and spinal cord.
December 3, 2020
News
Pulmonary fibrosis is one of the most common and serious types of lung disease. Now NIBIB-funded researchers have developed an in vitro lung tissue-on-a-chip system that mimics lung fibrosis, offering rapid testing of potential new anti-fibrotic treatments.
December 9, 2020
News
Researchers funded by NIBIB have launched a six-month pilot study in Lima, Peru, using smartphones and computer-aided tools to rapidly screen people for TB. The smartphone-based system will shorten the wait time for diagnosis from weeks to hours. Rapid diagnosis, in turn, will reduce the transmission of TB to others and hasten the start of medications.